All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YC1120 | Human anti-ST6GALNAC2 T cell receptor (BG2), pCDTCR1 | Human | BG2 | Human | LLFALYFSA | HLA-A2 | Lentiviral vector | |
TCR-YC1121 | Human anti-ST6GALNAC2 T cell receptor (KA10), pCDTCR1 | Human | KA10 | Human | LLFALYFSA | HLA-A2 | Lentiviral vector | |
TCR-YC1122 | Human anti-ST6GALNAC2 T cell receptor (LD11), pCDTCR1 | Human | LD11 | Human | LLFALYFSA | HLA-A2 | Lentiviral vector | |
TCR-YC1123 | Human anti-ST6GALNAC2 T cell receptor (OH7), pCDTCR1 | Human | OH7 | Human | LLFALYFSA | HLA-A2 | Lentiviral vector | |
TCR-YC1124 | Human anti-ST6GALNAC2 T cell receptor (SB8), pCDTCR1 | Human | SB8 | Human | LLFALYFSA | HLA-A2 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION